Theodrenaline: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{Drugbox
<div style="float: right;">
| IUPAC_name        = 7-[2-[ [2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]ethyl]-1,3-dimethylpurine-2,6-dione
[[File:Theodrenaline.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div>
| image            = theodrenaline.png
 
| CAS_number        =
| ATC_prefix        = C01
| ATC_suffix        = CA23
| PubChem          = 71857
| DrugBank          =
| C=17|H=21|N=5|O=5
| molecular_weight  = 375.379 g/mol
| bioavailability  =
| protein_bound    =
| metabolism        =
| elimination_half-life =
| excretion        =
| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      =  <!-- A / B            / C / D / X -->
| pregnancy_category= 
| legal_AU          =  <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA          =  <!--            / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK          =  <!-- GSL        / P      / POM / CD / Class A, B, C -->
| legal_US          =  <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status      =
| routes_of_administration =
}}
__NOTOC__
__NOTOC__
{{SI}}
{{SI}}
{{CMG}}
{{CMG}}
==Overview==
'''Theodrenaline''' ([[International Nonproprietary Name|INN]]), also known as '''noradrenalinoethyltheophylline''', is a chemical linkage of [[norepinephrine]] (noradrenaline) and [[theophylline]] used as a [[cardiac stimulant]].


==Overview==
 
'''Theodrenaline''' (or '''noradrenaline theophylline''') is a cardiac stimulant.  It is sometimes combined with [[cafedrine]].<ref name="pmid16633089">{{cite journal |author=Usichenko TI |title=Akrinor-induced relaxation of pig coronary artery in vitro is transformed into alpha1-adrenoreceptor-mediated contraction by pretreatment with propranolol |journal=J. Cardiovasc. Pharmacol. |volume=47 |issue=3 |pages=450–5 |date=March 2006 |pmid=16633089 |doi=10.1097/01.fjc.0000211710.87863.89 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005344-200603000-00017 |author-separator=, |author2=Foellner S |author3=Gruendling M |display-authors=3 |last4=Feyerherd |first4=F |last5=Lehmann |first5=C |last6=Wendt |first6=M |last7=Pavlovic |first7=D}}</ref>
It is sometimes combined with [[cafedrine]].<ref name="pmid16633089">{{cite journal |author=Usichenko TI |title=Akrinor-induced relaxation of pig coronary artery in vitro is transformed into alpha1-adrenoreceptor-mediated contraction by pretreatment with propranolol |journal=J. Cardiovasc. Pharmacol. |volume=47 |issue=3 |pages=450–5 |date=March 2006 |pmid=16633089 |doi=10.1097/01.fjc.0000211710.87863.89 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005344-200603000-00017 |author-separator=, |author2=Foellner S |author3=Gruendling M |display-authors=3 |last4=Feyerherd |first4=F |last5=Lehmann |first5=C |last6=Wendt |first6=M |last7=Pavlovic |first7=D}}</ref>
 
==See also==
* [[Cafedrine]]
* [[Fenethylline]]


==References==
==References==
{{reflist|2}}
{{Reflist|2}}


{{Cardiac stimulants excluding cardiac glycosides}}
{{Cardiac stimulants excluding cardiac glycosides}}
{{Adenosinergics}}
{{Adrenergics}}


[[Category:Adenosine receptor antagonists]]
[[Category:Catecholamines]]
[[Category:Catecholamines]]
[[Category:Cardiac stimulants]]
[[Category:Xanthines]]
[[Category:Xanthines]]
[[Category:Cardiovascular Drugs]]
[[Category:Drug]]
[[Category:Drug]]

Revision as of 18:45, 7 April 2015

This image is provided by the National Library of Medicine.


WikiDoc Resources for Theodrenaline

Articles

Most recent articles on Theodrenaline

Most cited articles on Theodrenaline

Review articles on Theodrenaline

Articles on Theodrenaline in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Theodrenaline

Images of Theodrenaline

Photos of Theodrenaline

Podcasts & MP3s on Theodrenaline

Videos on Theodrenaline

Evidence Based Medicine

Cochrane Collaboration on Theodrenaline

Bandolier on Theodrenaline

TRIP on Theodrenaline

Clinical Trials

Ongoing Trials on Theodrenaline at Clinical Trials.gov

Trial results on Theodrenaline

Clinical Trials on Theodrenaline at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Theodrenaline

NICE Guidance on Theodrenaline

NHS PRODIGY Guidance

FDA on Theodrenaline

CDC on Theodrenaline

Books

Books on Theodrenaline

News

Theodrenaline in the news

Be alerted to news on Theodrenaline

News trends on Theodrenaline

Commentary

Blogs on Theodrenaline

Definitions

Definitions of Theodrenaline

Patient Resources / Community

Patient resources on Theodrenaline

Discussion groups on Theodrenaline

Patient Handouts on Theodrenaline

Directions to Hospitals Treating Theodrenaline

Risk calculators and risk factors for Theodrenaline

Healthcare Provider Resources

Symptoms of Theodrenaline

Causes & Risk Factors for Theodrenaline

Diagnostic studies for Theodrenaline

Treatment of Theodrenaline

Continuing Medical Education (CME)

CME Programs on Theodrenaline

International

Theodrenaline en Espanol

Theodrenaline en Francais

Business

Theodrenaline in the Marketplace

Patents on Theodrenaline

Experimental / Informatics

List of terms related to Theodrenaline

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Theodrenaline (INN), also known as noradrenalinoethyltheophylline, is a chemical linkage of norepinephrine (noradrenaline) and theophylline used as a cardiac stimulant.


It is sometimes combined with cafedrine.[1]

See also

References

  1. Usichenko TI; Foellner S; Gruendling M; et al. (March 2006). "Akrinor-induced relaxation of pig coronary artery in vitro is transformed into alpha1-adrenoreceptor-mediated contraction by pretreatment with propranolol". J. Cardiovasc. Pharmacol. 47 (3): 450–5. doi:10.1097/01.fjc.0000211710.87863.89. PMID 16633089. Unknown parameter |author-separator= ignored (help)

Template:Cardiac stimulants excluding cardiac glycosides